Cognis Health & Nutrition (La Grange, IL) has exclusively licensed two new active ingredients for weight management and cognitive performance from InterMed Discovery (IMD; Dortmund, Germany).
Cognis Health & Nutrition (La Grange, IL) has exclusively licensed two new active ingredients for weight management and cognitive performance from InterMed Discovery (IMD; Dortmund, Germany).
Cognis says that both ingredients show promising benefits based on IMD’s testing, including in vivo tests. Cognis plans to conduct its own testing on the ingredients this year.
Cognis has already licensed four other ingredients from IMD for weight management and heart health. A clinical test on one of the four ingredients will begin later this year, while the other ingredients are in advanced preclinical testing and scale-up mode.
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.